Yayınlar & Eserler

Yayın Ağı
Makaleler 15
Tümü (15)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (15)
Scopus (15)

1. Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months

YILMAZ S., EKEN A., SEZER Z., Bagci B. S., Erdem S., Sarikaya M. D., et al.
FRONTIERS IN MEDICINE , cilt.12, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

2. Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants

Kaplan B., Pavel S. T. I., Uygut M. A., Tunc M., Eroksuz Y., Celik I., et al.
VACCINES , cilt.13, sa.2, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

3. Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up

Sezer Z., Pavel S. T. I., Inal A., Yetiskin H., Kaplan B., Uygut M. A., et al.
VACCINES , cilt.12, sa.2, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

4. Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials

Ozdarendeli A., Sezer Z., Pavel S. T. I., Inal A., Yetiskin H., Kaplan B., et al.
VACCINE , cilt.41, sa.2, ss.380-390, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

5. SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants

Mamedov T., Yuksel D., Gurbuzaslan I., Gulec B., Mammadova G., Özdarendeli A., et al.
Frontiers in Plant Science , cilt.14, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

6. Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants

Mamedov T., Yuksel D., Gurbuzaslan I., Ilgin M., Gulec B., Mammadova G., et al.
FRONTIERS IN PLANT SCIENCE , cilt.14, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

7. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2

Yetişkin H., Kaplan B., Pavel S. T. I., Özdarendeli A.
FRONTIERS IN IMMUNOLOGY , cilt.13, ss.824378, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

8. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.

Taşlı N. P., Gönen Z. B., Kırbaş O. K., Gökdemir N. S., Bozkurt B. T., Bayrakçı B., et al.
FRONTIERS IN IMMUNOLOGY , cilt.13, ss.1-15, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Development of an Inactivated Vaccine against SARS CoV-2

Pavel S. T. I., Yetiskin H., Uygut M. A., Aslan A. F., Aydın G., Inan Ö., et al.
VACCINES , cilt.9, sa.11, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

10. Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19

Mamedov T., Yuksel D., Ilgın M., Gürbüzaslan I., Gulec B., Mammadova G., et al.
VACCINES , cilt.9, sa.11, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

11. Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice

Mamedov T., Yuksel D., Ilgın M., Gurbuzaslan I., Gulec B., Yetiskin H., et al.
VIRUSES-BASEL , cilt.13, sa.8, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

12. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model

Pavel S. T. I., Yetiskin H., Kalkan A., Ozdarendeli A.
PLOS NEGLECTED TROPICAL DISEASES , cilt.14, sa.11, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

13. Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey

PAVEL S. T. I., YETİŞKİN H., AYDIN G., Holyavkin C., UYGUT M. A., Dursun Z. B., et al.
PLoS ONE , cilt.15, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

14. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

Alm E., Broberg E. K., Connor T., Hodcroft E. B., Komissarov A. B., Maurer-Stroh S., et al.
Eurosurveillance , cilt.25, sa.32, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

15. Francisella is sensitive to insect antimicrobial peptides.

Vonkavaara M., Pavel S. T. I., Hölzl K., Nordfelth R., Sjöstedt A., Stöven S.
Journal of innate immunity , cilt.5, ss.50-9, 2013 (SCI-Expanded, Scopus) identifier identifier identifier
Kitaplar 2

1. AŞI ÇALIŞMALARI VE TEKNOLOJİSİ

Özdarendeli A., Pavel S. T. I., Yetişkin H., Uygut M. A., Kaplan B.
Nobel Tıp Kitapevi, İstanbul, 2023

2. İnaktif Viral Aşılar

ÖZDARENDELİ A., PAVEL S. T. I., YETİŞKİN H., UYGUT M. A., KAPLAN B.
AŞI ÇALIŞMALARI VE TEKNOLOJİSİ, Mert Döşkaya ,Adnan Yüksel Gürüz, Ayşe Gülten Kantarcı, Cemal Ün, Editör, Nobel Tıp Kitabevleri Tic. Ltd. Şti., İstanbul, ss.285-298, 2023 Sürdürülebilir Kalkınma
Metrikler

Yayın

28

Yayın (WoS)

15

Yayın (Scopus)

15

Atıf (WoS)

283

H-İndeks (WoS)

9

Atıf (Scopus)

364

H-İndeks (Scopus)

8

Atıf (Scholar)

515

H-İndeks (Scholar)

9

Proje

7

Fikri Mülkiyet

3

Açık Erişim

7
BM Sürdürülebilir Kalkınma Amaçları